MyAverix Finance
AU · Healthcare
Zelira Therapeutics Ltd (ZLD)
Biotechnology
Zelira Therapeutics Ltd (ZLD) is listed on AU in the Healthcare sector. Industry: Biotechnology. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for ZLD
Zelira Therapeutics Ltd (ZLD) — FAQ
What is ZLD's P/E ratio?
The price-to-earnings (P/E) ratio for Zelira Therapeutics Ltd (ZLD) is 18.00 (data as of 2026-03-23).
Does Zelira Therapeutics Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Zelira Therapeutics Ltd (ZLD). Check the MyAverix Finance app for the latest dividend data.
What sector is Zelira Therapeutics Ltd in?
Zelira Therapeutics Ltd (ZLD) is classified in the Healthcare sector (Biotechnology industry).
What exchange is ZLD listed on?
ZLD is listed on AU.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.